Sarah Cannon Research Institute
Lily Wise is an experienced professional in the healthcare and technology sectors, currently serving as a Peer Reviewer at Sarah Cannon Research Institute since November 2024. Prior to this role, Lily worked as a Clinical Data Analyst at Sarah Cannon from December 2020 to November 2024. Significant contributions include statistical analysis and the development of a patient data application at Family Health Center in Waco as a Research Team Member and Researcher from June 2018 to January 2020. Additionally, Lily interned at Interpreta, analyzing trends in machine-learning applications for patient care, and held leadership roles at Baylor University, mentoring computer science students and leading New Student Programs. Lily holds a degree in Bioinformatics and Information Technology from Baylor University, completed in 2019.
This person is not in any teams
This person is not in any offices
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.